Riskpilot← Back to searchSign inGet full accessEQOLOGY.NO AS
ASActiveOrg 988393495Mustads Vei 1A, 0283 OsloRetail sale of other food · NACE 4727Est. 200514 employees
Revenue 2025
NOK 1,6B
+30% vs 2024
EBITDA margin
22.1%
+43% vs 2024
Equity ratio
41.1%
Financial strength
Net profit 2025
NOK 283,9M
+43% vs 2024
| Revenue | NOK 1,6B | +30% |
| EBITDA | NOK 356M | +43% |
| Net profit | NOK 283,9M | +43% |
| Total assets | NOK 698,2M | +61% |
| Equity | NOK 286,6M | +98% |
| Employees | 14 | — |
Legal name
EQOLOGY.NO AS
Org number
988393495
Legal form
Aksjeselskap
NACE code
4727 · Retail sale of other food
Founded
6. juli 2005
Share capital
NOK 100 000
Employees
14 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Handel innen helostmarkedet og andre markeder som står i naturlig forbindelse med helostmakedet. Samt alt som hermed er forbundet. Herunder å delta i andre selskaper.
Address
Mustads Vei 1A, 0283 Oslo
Phone
+4767492222
Email
support@eqology.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 336 031 | 421 504 | 821 291 | 1 237 313 | 1 613 826 |
| Staff expenses | −26 351 | −29 558 | −20 491 | −29 874 | −35 720 |
| EBITDA | 27 080 | 36 913 | 116 641 | 248 539 | 355 995 |
| Depreciation & amort. | −96 | −170 | −1 206 | −2 139 | −4 482 |
| EBIT | 26 985 | 36 743 | 115 435 | 246 400 | 351 513 |
| Net financials | −3 547 | 1 509 | 8 655 | 8 987 | 12 533 |
| Profit before tax | 23 437 | 38 252 | 124 090 | 255 386 | 364 046 |
| Tax | 5 158 | 8 440 | 27 349 | 56 191 | 80 099 |
| Net profit | 18 279 | 29 812 | 96 741 | 199 196 | 283 948 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 75 275 | 146 541 | 318 365 | 434 716 | 698 153 |
| Equity | 13 488 | 42 569 | 68 428 | 144 814 | 286 614 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 61 786 | 103 972 | 249 938 | 289 902 | 411 538 |
| Total debt | 61 786 | 103 972 | 249 938 | 289 902 | 411 538 |
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
20212025
Equity ratio
41.1%
This company
38.2%
Market median
+8% vs market
20212025
Return on equity
99.1%
This company
18.4%
Market median
+439% vs market
20212025
Net profit margin
17.6%
This company
8.1%
Market median
+117% vs market
20212025
Asset turnover
2.31×
This company
1.12×
Market median
+106% vs market
20212025
Debt / equity
1.44×
This company
0.62×
Market median
-132% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
RA Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KØ | Board of Directors | 2022 |
| Board of Directors | 2025 | |
| Chairman | 2022 | |
| Former (2) | ||
| Board of Directors | 2019 – 2022 | |
| Board of Directors | 2019 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Immunopharma As
EQOLOGY.NO AS Board members of EQOLOGY.NO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Roar Arnstad | Chief Executive Officer | 0 companies |
| Aleksander Rognerud Hetland | Board of Directors | 0 companies |
| Kim Øien | Board of Directors | 0 companies |
| Gunnar Christian Detlie | Board of Directors | 0 companies |
| Frode Marc Bohan | Board of Directors | 0 companies |
| Knut Christian Espeseth | Chairman | 0 companies |